17-49042297-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006546.4(IGF2BP1):āc.997A>Gā(p.Ile333Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000266 in 1,614,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006546.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGF2BP1 | NM_006546.4 | c.997A>G | p.Ile333Val | missense_variant | 9/15 | ENST00000290341.8 | NP_006537.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGF2BP1 | ENST00000290341.8 | c.997A>G | p.Ile333Val | missense_variant | 9/15 | 1 | NM_006546.4 | ENSP00000290341.3 | ||
IGF2BP1 | ENST00000431824.2 | c.580A>G | p.Ile194Val | missense_variant | 7/13 | 1 | ENSP00000389135.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251346Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135858
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1461822Hom.: 0 Cov.: 31 AF XY: 0.0000399 AC XY: 29AN XY: 727220
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2022 | The c.997A>G (p.I333V) alteration is located in exon 9 (coding exon 9) of the IGF2BP1 gene. This alteration results from a A to G substitution at nucleotide position 997, causing the isoleucine (I) at amino acid position 333 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at